As of 30 September 2026, 3 Indian mutual funds hold Advanced Enzyme Technologies Limited (Healthcare), led by UTI - MNC Fund at 1.15% of its net assets, per the AMCs' SEBI-mandated monthly disclosures.
As of 30 September 2026, 3 Indian mutual fund schemes disclose a holding in Advanced Enzyme Technologies Limited (Healthcare). The table below lists every fund holding this stock along with its weight as a percentage of the fund's net assets (% to NAV), sorted from the highest conviction position downward.
Across the 3 funds holding Advanced Enzyme Technologies Limited, the average position size is 0.43% of net assets. The highest-conviction holder is UTI - MNC Fund (Thematic), at 1.15%. Equity funds account for 2 of the 3 holders, with the rest spread across 1 other category. Over the last month, 0 funds initiated a new position and 1 fund exited.
How funds changed their Advanced Enzyme Technologies Limited position between their two latest monthly disclosures. Weights are % to NAV; weight moves can also reflect price changes, not only buying or selling.
| # | Fund | AMC | Category | % to NAV |
|---|---|---|---|---|
| 1 | UTI - MNC Fund | UTI Mutual Fund | Thematic | 1.15% |
| 2 | Bank of India ELSS Tax Saver Fund | Bank of India Mutual Fund | Equity | 0.08% |
| 3 | JioBlackRock Flexi Cap Fund | Jio BlackRock Mutual Fund | Equity | 0.06% |
Want to interpret these weights? Read How to Read a Mutual Fund's Monthly Portfolio Disclosure, or look up terms like % to NAV and conviction in the glossary.
Source: SEBI-mandated monthly portfolio disclosures by Indian AMCs. Percentages are of each fund's net assets on its latest disclosure date. For information only, not investment advice.